Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Genscript Biotech Corp    1548   KYG3825B1059

GENSCRIPT BIOTECH CORP

(1548)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
05/17/2019 05/20/2019 05/21/2019 05/22/2019 05/23/2019 Date
18.26 16.88 16.78 17.06 16.5 Last
6523080 10602583 7592802 5278887 5845628 Volume
-5.09% -7.56% -0.59% +1.67% -3.28% Change
Financials (HKD)
Sales 2019 2 146 M
EBIT 2019 199 M
Net income 2019 160 M
Debt 2019 -
Yield 2019 -
Sales 2020 2 776 M
EBIT 2020 219 M
Net income 2020 178 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 171,80
P/E ratio 2020 131,74
Capi. / Sales2019 14,8x
Capi. / Sales2020 11,4x
Capitalization 31 654 M
More Financials
Company
Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and... 
More about the company
Surperformance© ratings of Genscript Biotech Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GENSCRIPT BIOTECH CORP
04/17GENSCRIPT BIOTECH : Chinese CDMO, GenScript starts construction of Biotech Comme..
AQ
04/16GENSCRIPT BIOTECH : Chinese CDMO GenScript starts construction of GenScript-Lege..
AQ
03/19Germany's Merck to Work With GenScript to Expand Cell and Gene Therapies in C..
DJ
02/04China Resources, Charoen Pokphand launch $300M life science fund
AQ
2018Amgen antibody shows promise in myeloma trial, gets FDA fast track
RE
2018GENSCRIPT BIOTECH : Bio buys back 500,000 shares
AQ
2018GENSCRIPT BIOTECH : Bio takes legal actions against Flaming Research
AQ
2018JOHNSON & JOHNSON : Short seller accuses GenScript of CAR T data fraud
AQ
2018GENSCRIPT BIOTECH : Stock of China's GenScript Plummets on Report Critical of Un..
DJ
2018GENSCRIPT BIOTECH : Bio inks cancer drug's license & development deal
AQ
More news
Sector news : Bio Diagnostics & Testing
05/21Global chemical firms urged to source responsibly after lethal China blast - ..
RE
05/15GILEAD SCIENCES : Novartis gets approval to sell Kymriah in Japan for $306,000
RE
05/13REGENERON PHARMACEUTICALS : Says FDA Approves Eylea Injection for All Diabetic R..
DJ
05/10PATRICK THOMAS : Biotech Industry Woos Talent With Top Pay -- WSJ
DJ
05/09PATRICK THOMAS : Biotech Is Place to Be for Top Salaries
DJ
More sector news : Bio Diagnostics & Testing
Chart GENSCRIPT BIOTECH CORP
Duration : Period :
Genscript Biotech Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENSCRIPT BIOTECH CORP
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 35,3  HKD
Spread / Average Target 107%
EPS Revisions
Managers
NameTitle
Fang Liang Zhang Chairman & Chief Executive Officer
Ye Wang President, COO & Executive Director
Jian Ge Meng Executive Director & VP-Investor Relations
Lu Quan Wang Non-Executive Director
Yue Xin Pan Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORP62.48%4 033
GUARDANT HEALTH INC90.21%6 654
IOVANCE BIOTHERAPEUTICS INC87.91%2 001
INVITAE CORP--.--%1 655
CAREDX INC32.10%1 432
MIRACA HOLDINGS INC.4.03%1 316